已核实 DOI PubMed 相关产品: 0

Stabilizing MARCH7 as a ferro-guardian against ferroptosis

Journal 2026 · IF 45.1 · 发表于 2026 年 4 月 27 日
作者: Wenxiang Huang,Ruijun Wang,Xinquan Yang,Shuangjie Yang,Xueliang Yang,Gaolu He,Songjun Dai,Caizhi Li,Lianchao Gao,Tingting Zhang,Peng Zhang,Ruihan Chen,Keke Zheng,Junbing Wu,Junxia Min,Qian Ba,Fudi Wang,Qiang Zhang
阅读全文 在 PubMed 查看

摘要

Ferroptosis is an iron-dependent form of regulated cell death. However, the critical regulators that restrain iron overload to suppress ferroptosis remain undefined. Utilizing multi-omics, we identify the E3 ubiquitin ligase membrane-associated RING-CH 7 (MARCH7) as a non-redundant, dual suppressor of ferroptosis via direct regulation of intracellular iron homeostasis. Mechanistically, MARCH7 ubiquitylates nuclear receptor coactivator 4 (NCOA4) at residue Lys42 by K48-linked ubiquitination, promoting NCOA4 proteasomal degradation and reducing the labile iron pool. Concomitantly, MARCH7 modifies transferrin receptor 1 (TFR1) at residue Lys53 by K63 ubiquitination, restricting its plasma membrane translocation and thereby inhibiting cellular iron uptake. Through high-content screening, we further identify emodinanthrone (EmodAn) as a specific MARCH7 stabilizer with a strong cardioprotective effect in rodent models by blocking ferroptosis. In conclusion, our findings define an iron homeostasis regulatory hub for ferroptosis and suggest that stabilizing MARCH7 is a promising therapeutic strategy to protect against ferroptosis- or iron-overload-induced diseases.